MENU
SABS
AS OF
Dec 12 closing price
Price
$3.81
Change
+$0.22 (+6.13%)
Capitalization
181.38M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
SABS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SAB Biotherapeutics (SABS) Ownership - Who owns SAB Biotherapeutics?

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
181.38M
P/E Ratio
N/A
Total Cash
110.88M
Projected Growth
N/A
Total Debt
6.19M
Revenue
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash/Share
2.33
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SABS
Capitalization
181M
P/E Ratio
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash
111M
Total Cash/Share
2.33
Total Debt
6.19M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
165M
P/B Ratio
1.10
Cash Flow
N/A
Earnings
-0.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4.76K
Current Ratio
10.50
Current Revenue Per Employee
10376.80
Dividends Per Share - Security
N/A
EBITDA
22.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
15.80
Shares Held By Institutions
57.6M
Shares Outstanding - Current
47.6M
Total Liabilities
18.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-5.382
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SABS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for SABS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com